Siderophore-Enabled Delivery of Carbapenem and Metallo-β-Lactamase Inhibitor: A Promising Strategy against…

Abstract

Carbapenem-resistant Pseudomonas aeruginosa (CRPA), a World Health Organization high-priority pathogen, represents a major clinical threat due to limited treatment options. Its intrinsic resistance is driven in part by extremely low outer-membrane permeability, which restricts antibiotic uptake, while the increasing prevalence of metallo-β-lactamase (MBL)-producing strains, particularly NDM-expressing isolates, poses a critical therapeutic challenge, conferring resistance to both carbapenems and cefiderocol, with few effective inhibitors available. In this study, we evaluated the potential of a series of unique biomimetic siderophore conjugates in combating CRPA. As an initial approach, tris-catecholate siderophore-meropenem conjugates were synthesized and demonstrated to overcome nonenzymatic carbapenem resistance in P. aeruginosa, including porin loss and efflux upregulation, in an iron-dependent manner. We then targeted MBL-expressing CRPA by vectorizing a recently developed broad-spectrum MBL inhibitor, indole carboxylates (InC), which is largely ineffective against P. aeruginosa, likely due to poor permeability. These conjugates restored inhibitor activity and effectively reversed meropenem and cefiderocol resistance in MBL-producing clinical isolates, both in vitro and in a Galleria mellonella infection model. Together, these findings highlight the design and potential of siderophore conjugates as a versatile platform to revive the efficacy of life-saving antibiotics against multidrug-resistant Gram-negative pathogens.

Interfacial Assembly of Marine Exopolysaccharide EPS MO245 Reduces Pseudomonas aeruginosa Adhesion on Silica
Marie Champion, Jean-Paul Chapel, Xavier Moppert +3
Colloids and Surfaces A: Physicochemical and Engineering Aspects18 Sep 2026Peer-reviewedCC BY 4.0Full textSystems & synthetic biology Materials & polymersHAL
Fabrication of a paper-based microextraction tool for monitoring volatile emission associated with Pseudomonas aeruginosa
Ashna Chandran M K, Debsmita Mandal, Keerthana Selvamuthukumar +2
Scientific Reports15 Oct 2026Peer-reviewedCC BY 4.0Full textAnalytical chemistryCrossref
Stable Phosphonate Inhibitors of Elastase LasB Suppress Pseudomonas aeruginosa Virulence via Zinc-Targeting Pyrrolidone Scaffolds
Gwenaëlle Jézéquel, Dominik Kolling, Roya Shafiei +5
HAL20 Aug 2026PreprintCC BY-NC-ND 4.0Full textGeneral chemistryHAL
Azobenzene-bridged potent divalent ligands of Pseudomonas aeruginosa LecA
Yu Fan, Barbora Svomova, Martin Lepsik +6
Bioorganic Chemistry30 Sep 2026Peer-reviewedCC BY 4.0Full textMaterials & polymersHAL
Neutron Crystallography Maps the Interaction Landscape of Pseudomonas aeruginosa LecA with Deuterated Aromatic β-Galactoside
Theodore Arnaud, Delphine Carry, Chloé Tatol +10
ChemRxiv21 Sep 2026PreprintCC BY-NC-ND 4.0Full textMaterials & polymersChemRxivHAL

Cite

BibTeX RIS

BibTeX

@article{safari2026siderophoreenabled,
  title = {{Siderophore-Enabled Delivery of Carbapenem and Metallo-β-Lactamase Inhibitor: A Promising Strategy against Multidrug-Resistant Pseudomonas aeruginosa}},
  author = {Shahriar Safari and Ravil Petrov and Yulia Ustimenko and Katy Jeannot and Xavier Trivelli and Ernesto Anoz-Carbonell and Ruben C. Hartkoorn},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  month = sep,
  doi = {10.1021/jacs.6c08350},
  url = {https://hal.science/hal-05780355v1},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Siderophore-Enabled Delivery of Carbapenem and Metallo-β-Lactamase Inhibitor: A Promising Strategy against Multidrug-Resistant Pseudomonas aeruginosa
AU  - Shahriar Safari
AU  - Ravil Petrov
AU  - Yulia Ustimenko
AU  - Katy Jeannot
AU  - Xavier Trivelli
AU  - Ernesto Anoz-Carbonell
AU  - Ruben C. Hartkoorn
PY  - 2026
DA  - 2026/09/27
JO  - Journal of the American Chemical Society
DO  - 10.1021/jacs.6c08350
UR  - https://hal.science/hal-05780355v1
AB  - Carbapenem-resistant Pseudomonas aeruginosa (CRPA), a World Health Organization high-priority pathogen, represents a major clinical threat due to limited treatment options. Its intrinsic resistance is driven in part by extremely low outer-membrane permeability, which restricts antibiotic uptake, while the increasing prevalence of metallo-β-lactamase (MBL)-producing strains, particularly NDM-expressing isolates, poses a critical therapeutic challenge, conferring resistance to both carbapenems and cefiderocol, with few effective inhibitors available. In this study, we evaluated the potential of a series of unique biomimetic siderophore conjugates in combating CRPA. As an initial approach, tris-catecholate siderophore-meropenem conjugates were synthesized and demonstrated to overcome nonenzymatic carbapenem resistance in P. aeruginosa, including porin loss and efflux upregulation, in an iron-dependent manner. We then targeted MBL-expressing CRPA by vectorizing a recently developed broad-spectrum MBL inhibitor, indole carboxylates (InC), which is largely ineffective against P. aeruginosa, likely due to poor permeability. These conjugates restored inhibitor activity and effectively reversed meropenem and cefiderocol resistance in MBL-producing clinical isolates, both in vitro and in a Galleria mellonella infection model. Together, these findings highlight the design and potential of siderophore conjugates as a versatile platform to revive the efficacy of life-saving antibiotics against multidrug-resistant Gram-negative pathogens.
SN  - 0002-7863
SN  - 1520-5126
ER  -

Abstract

Related

Cite